An alternative to harvesting environmentally-destructive palm oil? Here’s a biotech solution using soybeans

It takes a lot of complicated technology to make even simple bio-products at scale. Credit: Evologic Technologies
It takes a lot of complicated technology to make even simple bio-products at scale. Credit: Evologic Technologies

Plant-based synthetic biology continues to play a role in novel ingredient discovery, which ultimately helps alleviate global food chains from socio-economic and environmental strains. In this space, Calyxt has completed the first phase of its research project to develop an “improved soybean” capable of producing an oil as a commercial alternative to palm oil.

This development comes at a crucial time in the international dialogue regarding the deforestation impact of traditional palm oil sourcing and production.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Calyxt’s technology platform, PlantSpring, is founded on its more than a decade of research in engineering plant metabolism.

The process includes the identification of breakthrough plant compounds based on customer needs, designing strategies to reprogram host cells, engineering plant cell metabolism to optimally produce targeted plant-based chemistries, and producing those target chemistries at laboratory scale.

PlantSpring operates on AI and machine learning capabilities. These help the company process knowledge gained from past research activities, which can be combined with predictive analytics to rapidly prototype and provide feedback.

All in all, the company says this accelerates the time to complete the “design-engineer-verify” development cycle of newly discovered food compounds, while helping mitigate the risks associated with commercial scale-up.

Calyxt has begun the second and final phase of the research collaboration and expects to complete its final phase in the first quarter of 2024.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
The Orange Bowl without oranges: Can CRISPR save Florida citrus?
ChatGPT-Image-May-22-2026-10_26_09-AM
Gutting the National Science Board: How the Trump-RFK, Jr. crusade is erasing the separation of science and state
Screenshot-2026-04-14-at-11.11.06-AM
‘Turbo cancer’ or mRNA cancer cure? Strategies to counter misinformation
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Screenshot 2025-11-12 at 3.28
GLP podcast: Evolutionary biologist debunks the 'sex spectrum'
Screenshot 2026-05-22 at 3.28
Vagus nerve wellness grift: How to build a billion dollar business. Are you listening, Kelly Ripa?
ChatGPT-Image-May-26-2026-09_19_32-AM
Viewpoint— “A safe space to chat, flirt, and be intimate without sex”: Are new AI companies exploiting vulnerable asexuals?
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-May-26-2026-09_04_31-AM-2
Hantavirus revives COVID-era conspiracies and distrust in public health 
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.